Gladstone in the News
April 27, 2023
Popular Science—A new study from Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, indicates that chance structural changes in the human genome were what allowed humans to evolve the larger brains that set us apart from our primate ancestors.
Gladstone Experts
Data Science and Biotechnology
Pollard Lab
Genomics
Human Genetics
Gladstone in the News
April 25, 2023
Innovative Genomics Institute—Work from Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and Affiliate Investigator Justin Eyquem demonstrates a new, more efficient and gentle method to introduce CRISPR editing machinery into cells.
Gladstone Experts
Genomic Immunology
Eyquem Lab
Marson Lab
CRISPR/Gene Editing
Gladstone in the News
April 5, 2023
National Institutes of Health—Senior Investigator Katie Pollard, PhD, is featured for her work on genome organization during heart development and talks about her career path in a recent highlight of the National Institutes of Health's 4D Nucleome program.
Gladstone Experts
Data Science and Biotechnology
Pollard Lab
Genomics
Gladstone in the News
March 23, 2023
The Wall Street Journal—Induced pluripotent stem cells have the potential to be used in innovative therapies for conditions like for Parkinson’s disease, macular degeneration, and heart failure. Gladstone Senior Investigator Shinya Yamanaka, who was the first to develop the technology, describes how a patient’s own cells can be used to generate tissue for transplantation.
Gladstone Experts
Yamanaka Lab
Stem Cells/iPSCs
Gladstone in the News
January 26, 2023
Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.
Gladstone Experts
Cancer
Genomic Immunology
Marson Lab
CRISPR/Gene Editing
Gladstone in the News
December 10, 2022
San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.
Gladstone Experts
COVID-19
Virology
Roan Lab
Gladstone in the News
December 2, 2022
San Francisco Chronicle—Although requirements for mask wearing and social distancing have eased around the country, a third winter of the pandemic is looming. Gladstone Senior Investigator Warner Greene recommends paying attention to local trends in case numbers to decide which COVID-19 precautions to take.
Gladstone Experts
COVID-19
Virology
Greene Lab
